Position in GALT
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$30,809
-$15,129 QoQ
Shares Held
11,043
0.0% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 28%
Shared 0%
None 72%
Common Shares in GALT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026JPMORGAN CHASE & CO holds $16,579,226,864 across 407 Biotechnology names. GALT ranks #272 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
24,150,499 | $3,949,089,591 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,311,806 | $3,331,473,778 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,033,156 | $3,140,585,469 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
6,323,752 | $2,092,339,815 | |
| 5 | NUVL |
Nuvalent, Inc.
|
3,088,349 | $316,401,351 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,204,353 | $227,682,931 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
2,363,567 | $177,480,242 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
2,869,728 | $151,292,056 |
All Filings in GALT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $30,809 | 11,043 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $45,938 | 11,043 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $65,591 | 15,470 | Shares | Defined | 2025-11-26 | |
| 2025-06-30 | $26,030 | 12,337 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $20,696 | 16,965 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $77,002 | 59,693 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $84,226 | 30,628 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $26,489 | 11,721 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $4,470 | 1,871 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $3,025 | 1,823 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $178 | 93 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $61 | 43 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $90 | 43 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $48 | 43 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $70 | 43 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $56 | 43 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $69 | 43 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $89 | 43 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $166 | 43 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $137 | 43 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $218,203 | 100,555 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $232,317 | 103,713 | Shares | Defined | 2021-02-19 | |
| 2020-09-30 | $57,869 | 21,674 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $85,713 | 28,011 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $79,573 | 40,599 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||